Literature DB >> 16553938

Analysis of deaths with an unknown cause in epidemiologic analyses of mortality burden.

Alexander K Rowe1.   

Abstract

OBJECTIVE: To describe options for analysing deaths with an unknown cause, which often occur in community-based studies that are used to estimate disease-specific mortality burden and trends in low-income countries.
METHODS: Mathematical formulae were derived that accommodate deaths with an unknown cause for the disease-specific mortality rate, proportion of deaths attributable to the disease and all-cause mortality rate. Seven specific options are presented, including example calculations from a study of childhood malaria mortality in The Gambia. An algorithm is proposed to help make decisions on analysing deaths with an unknown cause.
RESULTS: In the Gambian study, 25.2% of deaths had an unknown cause. Three options would result in 23.6% (minimum), 48.8% (maximum) and 28.7% (probably the best estimate) of deaths attributed to malaria. The best analysis option depends on the disease of interest: diseases for which the diagnostic method has high sensitivity and specificity (e.g., measles, neonatal tetanus) are best analysed assuming that deaths with an unknown cause never have this cause, while diseases for which specificity and/or sensitivity is low (e.g., malaria) are likely to account for some proportion of deaths with an unknown cause.
CONCLUSIONS: The most important aspects of analysing deaths with unknown cause are choosing appropriate assumptions, describing them explicitly and performing a sensitivity analysis. Studies of causes of death should report several key pieces of information on deaths with unknown cause to aid interpretation.

Entities:  

Mesh:

Year:  2006        PMID: 16553938     DOI: 10.1111/j.1365-3156.2006.01581.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  6 in total

Review 1.  The burden of malaria mortality among African children in the year 2000.

Authors:  Alexander K Rowe; Samantha Y Rowe; Robert W Snow; Eline L Korenromp; Joanna Rm Armstrong Schellenberg; Claudia Stein; Bernard L Nahlen; Jennifer Bryce; Robert E Black; Richard W Steketee
Journal:  Int J Epidemiol       Date:  2006-02-28       Impact factor: 7.196

2.  Design and testing for clinical trials faced with misclassified causes of death.

Authors:  Bart Van Rompaye; Els Goetghebeur; Shabbar Jaffar
Journal:  Biostatistics       Date:  2010-03-08       Impact factor: 5.899

3.  Estimating the Prevalence of Rare Diseases: Long-Chain Fatty Acid Oxidation Disorders as an Illustrative Example.

Authors:  Eliza Kruger; Paul McNiven; Deborah Marsden
Journal:  Adv Ther       Date:  2022-06-08       Impact factor: 4.070

4.  Decreasing childhood mortality and increasing proportion of malaria deaths in rural Burkina Faso.

Authors:  Heribert Ramroth; Robert P Ndugwa; Olaf Müller; Yazoume Yé; Ali Sié; Bocar Kouyaté; Heiko Becher
Journal:  Glob Health Action       Date:  2009-04-15       Impact factor: 2.640

5.  Characterization of two putative protein translocation components in the apicoplast of Plasmodium falciparum.

Authors:  Ming Kalanon; Christopher J Tonkin; Geoffrey I McFadden
Journal:  Eukaryot Cell       Date:  2009-06-05

6.  Malaria infection, disease and mortality among children and adults on the coast of Kenya.

Authors:  Alice Kamau; Grace Mtanje; Christine Mataza; Gabriel Mwambingu; Neema Mturi; Shebe Mohammed; Gerald Ong'ayo; Gideon Nyutu; Amek Nyaguara; Philip Bejon; Robert W Snow
Journal:  Malar J       Date:  2020-06-17       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.